ASIA-PACIFIC HEMATOLOGY CONSORTIUM
  • HOME
    • APHCON NEWS
    • About APHCON >
      • APHCON
    • APHCON BYLAWS
    • APHCON Executive Committee
    • PRESIDENT'S PAGE
    • APHCON Mentors
    • CLINICAL TRIAL NETWORK >
      • APHCON PI Page
  • CONFERENCES
  • MEMBERSHIP
    • MANUSCRIPT SUBMISSION
  • APHCON PUBLICATIONS
    • Aplastic Anemia Treatment Guidelines
    • MPN Practice Pattern
    • Aplastic Anemia Practice Pattern
    • AML Practice Pattern
    • ALL Practice Pattern
    • Hodgkin's Lymphoma Practice Pattern
    • CML Practice Pattern
    • Multiple Myeloma Practice Pattern
    • Non-Hodgkin's Lymphoma Practice Pattern
  • LIBRARY
    • SLIDES AND PRESENTATION >
      • AUBHO2015 Presentation Slides: Solid Tumor
      • AUBHO2015 Presentation Slides: Immunotherapy
      • AUBHO2015 Presentation Slides: Hematology
      • AUBHO2014 Presentation Slides
      • BTG2014 Slides LEUKEMIA
      • BTG2014 Slides LYMPHOMA
      • BTG2014 Slides MYELOMA
      • HAA2013 Slides
      • AUBH2013 Slides
      • BTG2013 Slides
      • BTG2013 Slides (Chinese Version)
      • Aplastic Anemia
      • Acute Lymphocytic Leukemia
      • Immune Thrombocytopenia
      • Acute Myelogenous Leukemia
      • Multiple Myeloma
      • Hodgkin's Lymphoma
      • Thrombosis and Bleeding
      • Non Hodgkin's Lymphoma
      • Stem Cell Transplant
      • Hematology
      • Myeloproliferative Disease
      • Chronic Myelogenous Leukemia
      • ACUTE LEUKEMIA CHANNEL
      • CHRONIC MYELOID LEUKEMIA CHANNEL
      • HODGKIN'S LYMPHOMA CHANNEL
    • PEER REVIEWED JOURNALS
  • Contact Us
  • APHCON YOUTH CONGRESS
  • BTG2019
    • BTG2019 Information
    • BTG2019 Agenda
    • BTG2019 Registration
    • BTG2019 Abstract Submission
    • BTG2019 Hotel
    • BTG2019 Exhibit Booth
    • BTG2019 Sponsorship
    • Contact Us
JOURNAL ACCESS LOGIN
Picture

Home

APHCON Executive Committee

Preceptorship Program

APHCON Mentors

Education

Clinical Trial Network

Treatment Guidelines

Membership Services

Online Library

Newsroom

APHCON MANUSCRIPT SUBMISSION

APHCON members can now submit their manuscripts for revision. Only completed manuscripts will be eligible for revisions. At this time three broad categories will be accepted: Malignant Hematology, Benign Hematology and Stem Cell Transplantation. All manuscripts must be submitted in word format and accompanied by a cover letter. All reviewed manuscripts are required to acknowledge APHCON during their final submission to peer-reviewed journal

ORIGINAL ARTICLE

_Maximum length for a Regular Article is 4,000 words of text - not counting the abstract, tables, figure legends, and references. Abstracts must not exceed 200 words and should be constructed as a single narrative paragraph with no subheadings or references. Submissions are limited to a total of 7 figures and tables, and digital images are required. References should be limited to 50. The sections of a Regular Article should be ordered Abstract, Introduction, Methods (must include sufficient information to allow readers to understand the article content), Results, Discussion, Acknowledgements, Authorship Contributions and Disclosure of Conflicts of Interest, References, Tables, Figure Legends, and Figures.

BRIEF REPORTS

_Short manuscripts definitively documenting either experimental results or informative clinical observations will be considered for publication in this category. Single-case reports or case series can almost never be accommodated, unless they elucidate very novel and important disease biology or approaches to therapy. Brief Reports are not intended to allow publication of incomplete or preliminary findings. The review process is equally rigorous as for Regular Articles and the acceptance rate is lower. Brief Reports may not exceed 1,200 words of text not counting the abstract, figure legends, and references; abstracts must not exceed 150 words and should be a single paragraph with no subheadings. Only 2 figures/tables and 25 references may be included. The sections of a Brief Report should be ordered as follows: Abstract, Introduction, Methods sufficiently informative to allow reproduction of the data, followed by a combined Results and Discussion section, Acknowledgements, Authorship Contributions and Disclosure of Conflicts of Interest, References, Tables, Figure Legends, and Figures.

LETTER TO EDITOR

_ Letters to the Editor can be reviewed for submission to various journals. These maybe written as stand alone articles or in response to controversial articles and may have good visibility. Letters should contain significant new primary data and require greater length and/or the inclusion of a figure to make very important points.

CASE REPORTS

_ Case reports are usually unlikely to be published, unless they offer truly novel and important new insights into disease biology or therapy. All clinical submissions must have been approved by an ethics committee or institutional review board. Letters should include no more than 500 words of text, 5–10 references, and 1 figure or table. No abstract is required, but a brief title is required.
copyright protected aphcon.org